Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.

Source:http://linkedlifedata.com/resource/pubmed/id/9739058

J. Clin. Invest. 1998 Sep 15 102 6 1239-48

Download in:

View as

General Info

PMID
9739058